Headquartered in Greenwood Village, Colorado, Ventrus Biosciences® is a privately held specialty pharmaceutical company focused on the late-stage development and commercialization of gastrointestinal products in areas of unmet need. Currently, Ventrus Biosciences has secured rights to three late-stage gastrointestinal products: diltiazem cream for the treatment of anal fissure; phenylephrine gel for the treatment of fecal incontinence; and iferanserin ointment for the treatment of hemorrhoids.